P/116/2010

Key facts

Active substance
Sodium sulfate/potassium sulfate/magnesium sulfate heptahydrate
Therapeutic area
Gastroentology-Hepatology
Decision number
P/116/2010
PIP number
P/116/2010
Pharmaceutical form(s)
Oral solution
Condition(s) / indication(s)
Diseases of the intestines
Route(s) of administration
Oral use
Contact for public enquiries
Ipsen Pharma

E-mail: paediatrics.plans@ipsen.com
Tel. +33 58335820

Decision type
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)

Decision

Topics

How useful was this page?

Add your rating